AMENDMENT No. 1 to the FACILITY USE AGREEMENT
Exhibit 10.3
AMENDMENT No. 1
to the
This Amendment No. 1 to the Facility Use Agreement (the “Agreement”) (hereinafter referred to as the “Amendment”) is made as of April 17, 2019 (the “Effective Date”), by and between the INSTITUTE FOR SYSTEMS BIOLOGY (“ISB”), a Washington non-profit corporation, and NEOLEUKIN (“User”), a Delaware Corporation. ISB and the Company are collectively referred to as the “Parties” and individually as a “Party”.
RECITALS
WHEREAS, The User and ISB are parties to a certain Facility Use Agreement (the “Agreement”) dated November December 4, 2018;
WHEREAS, The User and ISB desire to amend the Agreement to adjust the rentable square feet identified in the Agreement, as more particularly described in this Amendment No. 1. All other provisions of the Agreement remain in full force and effect; and
NOW, THEREFORE, the Parties hereby agree to amend the Agreement as follows:
| 1. | In paragraph 1.a., line one, delete two thousand thirty (2,030) in its entirety and insert three thousand five hundred (3,500); |
| 2. | Delete Exhibit C “Description of Space” in its entirety and replace with Exhibit C included in this Amendment. |
| INSTITUTE FOR SYSTEMS BIOLOGY
By: /s/ Xxxxx Xxxxxxx
Title: Director of Facilities & Operations
Date: April 17, 2019 |
NEOLEUKIN
By: /s/ Xxxxxxxx X. Xxxxxxxx
Title: CEO, Neoleukin Therapeutics
Date: April 17, 2019 | |||
EXHIBIT C
DESCRIPTION OF SPACE
Office space in the Xxxxxxxxx xxxxxx xx xxx 0xx xxxxx (X0) and lab space in the Xxxxx xxx xx xxx 0xx xxxxx (X0) as depicted below.
L4 Office Space
L3 Office Space
Note: Partial end cap, -80 strorage and space in room 389 are not depicted in this map.
